A full picture of the similarities between Family A and Family B GPCRs (G-protein coupled receptors) has been frustrated by the lack of clear homology between the respective sequences. Here, we review previous computational studies on GPCR dimerization in which the putative dimerization interfaces have been analysed using entropy, the ET (evolutionary trace) method and related methods. The results derived from multiple sequence alignments of Family A subfamilies have been mapped on to the rhodopsin crystal structure using standard alignments. Similarly, the results for the Family B alignments have been mapped on to the rhodopsin crystal structure using the 'cold-spot' alignment. For both Family A and Family B GPCRs, the sequence analysis indicates that there are functional sites on essentially all transmembrane helices, consistent with the parallel daisy chain model of GPCR oligomerization in which each GPCR makes interactions with a number of neighbouring GPCRs. The results are not too sensitive to the quality of the alignment. Molecular Dynamics simulations of the activation process within a single transmembrane bundle of the rhodopsin and the β 2 -adrenergic receptor have been reviewed; the key observation, which is consistent with other computational studies, is that there is a translation and bending of helix 6, which contributes to a significant opening out of the intracellular face of the receptor, as shown in the accompanying movies. The simulations required the application of specific experiment-derived harmonic and half-harmonic distance restraints and so the application of such simulations to Family B GPCRs requires considerable care because of the alignment problem. Thus, in order to address the alignment problem, we have exploited the observation that GCR1, a plant GPCR, has homology with Family A, Family B and Family E GPCRs. The resulting alignment for transmembrane helix 3 is presented.
Introduction
Family B G-protein coupled receptor (GPCRs), although less-well studied than Family A GPCRs, are interesting because their protein fold (in the N-terminus) is distinct from that of Family A and because they include a number of medically important GPCRs such as the VIP (vasoactive intestinal peptide) receptor, glucagon and the CGRP (calcitonin generelated peptide) receptor. The percentage identity between Family B and Family A GPCRs, for which there is a crystal structure (namely that of rhodopsin), is well below the level at which sequence alignment can be undertaken routinely. Indeed, even the properties of the amino acids are scarcely conserved between the families, let alone the identity. This alignment problem has frustrated studies to identify common mechanisms between the two families and has necessitated the deployment of non-standard alignment techniques. Nevertheless Family B receptor models have been built [1, 2] . Here, we review previous computational approaches to studying Family A-Family B dimerization, highlight our approach to studying GPCR activation and introduce a novel approach to addressing the Family A-Family B alignment.
Underpinning all of this work is the sequence alignment with rhodopsin, for which there is a crystal structure [3, 4] . The Family A-Family B GPCR alignments have generally been based on the cold-spot method of Frimurer and Bywater [5] . Here, a key assumption is that, although the identity or property of residues is not conserved between Family A and Family B, the position of the functional residues is conserved, making it possible to align on the position of the most conserved residues regardless of their identity or properties. This cold-spot approach is most effective when there are common distances between the functional residues in Family A and Family B (a principle that is also used in the BLAST algorithm [6] ). Our sequence-based studies of Family B and Family C dimerization [7, 8] have been based on this cold-spot alignment method [5] .
Sequence-based approaches to dimerization
Several bioinformatics approaches have been devised to identify functional residues at protein-protein interfaces, and most of these have been applied to understanding the nature and function of GPCR dimerization. These include correlated mutation analysis [9, 10] , ET (evolutionary trace) [11] , entropy [7, 13] , subtractive correlated mutations [14, 15] and the hidden-site class evolutionary model [16] . Unfortunately, the different methods give different answers in terms of which TM (transmembrane) helices are predicted to be the contact points. Thus theoretical studies have implicated TM2, TM3, TM5 and TM6 [7] , TM4, TM5 and TM6 [16] , TM1, TM4 and TM5 [14, 15] , and TM1 and TM4 [17] . This variation is not surprising since experimental studies have implicated most helices, e.g. TM6 of the β 2 -adrenergic, cholecystokinin and leukotriene B 4 receptors [18] [19] [20] , TM5 and TM6 [21, 22] of the adrenergic-muscarinic chimaera (inferred from Maggio et al. [23] ), TM4 of the dopamine D 2 receptor [24] [25] [26] , TM4 and TM5 of rhodopsin [27] , TM1 and TM7 of the α-adrenergic receptor [28] , and TM1 and TM4 of the chemokine receptor [17] . In contrast, there is currently no clear experimental information on Family B GPCR dimerization interfaces, either with another GPCR or with RAMPs (receptor-activity-modifying partners).
Correlated mutation analysis is very useful for highlighting a small number of specific key residues and has the advantage that the end point is rigorously defined. However, it does not usually define a contact area of several hundred square angstroms that would normally be buried in a protein-protein interface [29] . Because it only defines a few residues, it is likely to be particularly prone to errors in a multiple sequence alignment. The ET method and the related entropy method, on the other hand, are usually very good for highlighting contact areas. However, in the earliest incarnations [30] , the end point used to terminate the method was entirely subjective.
Because of the sequence alignment problem and the lack of a Family B structure, these sequence-based methods have generally only been applied to Family A receptors. However, using the cold-spot alignment strategy of Frimurer and Bywater [5] , we were able to carry out an ET analysis of several Family A receptor subfamilies, Family B receptors and Family C receptors. Sample results for the opsin family and Family B, regenerated from [7] , are shown in Figure 1 . The coloured residues indicate putative proteinprotein interaction sites. These studies indicated for the first time that all GPCRs (for which there was sufficient sequence information), regardless of family, had the potential to dimerize via their TM domains. At that time there was essentially no experimental evidence for Family B dimerization (or for dimerization of some of the Family A subfamilies) although Family B receptors have recently been shown to dimerize via their TM domains [31, 32] , at least in the case of the secretin and VIP receptors. Family C receptors were known to dimerize, but this was originally thought to occur via interactions between the C-terminal tails [33] , although the C-terminus was later shown not to be essential for dimerization. The opsins too were thought by many to be an exception to the emerging rule of GPCR dimerization because of the early classical studies on rhodopsin solubilized in detergent [34] , but in terms of the external functional patches predicted by ET and entropy, the opsins and Family B receptors are very similar to other Family A subfamilies [7] . An interesting observation to arise from these ET studies was the observation of two (rather than one) predicted interfaces on opposite faces of the GPCR [7, 35] , as shown in Figure 1 , giving rise to the suggestion that GPCRs could oligomerize [7] . Oligomerization has been inferred from ligand binding [36] and related studies [37, 38] and was later confirmed for rhodopsin with the observation of oligomers in the AFM (atomic force microscopy) studies of Liang et al. [27] . In the same way, the receptor interface on the G-protein was predicted by ET to be sufficiently large to bind two receptors in a stoichiometry of two receptors to one G-protein [7] , a prediction that has been verified experimentally by both cross-linking and small angle neuron scattering, albeit in an in vitro system [20] .
Nevertheless, despite these successful predictions, there are two weaknesses of the ET and related methods.
First, the method indicates functional sites, but does not indicate the nature of the interaction and so is not able to infer the interacting partner, or to distinguish between homodimerization and heterodimerization or between contact dimers and domain-swapped dimers. (Our original proposal on domain swapping was presented to explain the fascinating experiments of Maggio et al. [23] ; domain swapping is probably primarily a mechanism for functional rescue rather than the usual mechanism of dimerization [7] . Several publications have since 'disproved' domain swapping in GPCRs [19, 40, 41] , although domain swapping in the histamine H 1 receptor was demonstrated by Bakker [42] .) Secondly, the subjective nature of the end point can lead to under-or over-prediction. Monte Carlo methods in combination with a clustering algorithm were used to show that the ET functional sites were non-random [7] , but the early studies still used a visual method to determine the end point and so there was no guarantee that the predicted functional sites were optimal. To address this problem, we used a cluster score at each stage of the process and compared the cluster score for the emergent ET or entropy residues with that from 999 random distributions of the same number of residues as determined by ET, etc. We were therefore able to generate a Z-score and terminate the analysis at the maximum Z-score [13] . These results indicate a tendency to terminate the generation of the ET residues somewhat prematurely when the end point was determined visually [7, 35] , and now, given a more rational determination of the end point, it emerges that the functional patch extends to all helices around the Family A TM domains [13] . The predicted extended functional site for Family B is shown in Figure 2 , and this new result brings Family B clearly in line with Family A. Moreover, this observation is consistent with the experimental observation that all helices have been implicated in both previous computational and experimental studies, and with the observation of clusters [37] and of linear arrays of receptors observed in the AFM studies [27] . However, some caution should be expressed in interpreting studies of receptor oligomers. James et al. [43] have recently and controversially [44] questioned the extent of GPCR dimerization inferred from BRET (bioluminescence resonance energy transfer) studies. BRET studies have a tendency to point towards constitutive dimerization [45, 46] , whereas other studies indicate an equilibrium between monomers and dimers [20] , which may depend on the stabilizing effect of the environment [41] . Nevertheless, the conclusion for the purposes of this article is that Family B GPCRs contain very similar functional sites on the exterior face of the TM helices as Family A GPCRs and so should have similar dimerization properties. Further research beyond the realms of sequence analysis is required to fully understand this phenomenon.
The activation mechanism
Site-directed mutagenesis, site-directed spin-labelling, NMR, fluorescence spectroscopy, SCAM (substituted cysteine accessibility method) studies, disulfide bond formation under oxidizing conditions, studies of zinc binding to histidine residues (coloured in Figure 2) , BRET, theoretical studies and even X-ray crystallography have all been used to address the identity of the conformational changes that occur on activation, either on addition of a ligand or in constitutively active receptors. Each of these techniques has its particular strengths and yields different information about the activation process.
In order to harness this wealth of experimental information, we have encoded the experimental information as a set of distance constraints imposed as harmonic or half-harmonic restraints into Molecular Dynamics simulations, which have been focused on the activation mechanism in rhodopsin and in the β 2 -adrenergic receptor [49] . Typically, these have been encoded as distance restraints between the Cα or Cβ atoms of interacting residues. The restraints have been rigorously separated into those that apply to the inactive receptor and those that apply to the active receptor. Application of the inactive restraints does not move the model too much from the initial rhodopsin template. Application of the active restraints leads to considerable conformational change, provided that the key restraining interaction, which holds the structure in the inactive state, is neutralized. This key restraining interaction is the salt bridge between the arginine residue (340/3.50, universal numbering) of the DRY/ERY (Asp-Arg-Tyr/GluArg-Tyr) motif at the intracellular end of TM3 and the glutamate residue (600/6.30) at the intracellular end of TM6.
When the experimental information is taken together in this way and used in conjunction with Molecular Dynamics simulations [49] , a number of key features emerge, the most significant of which appear to be a bending and translation of TM6 [20, 51, 52] and an opening out of the internal face of the receptor [53] , presumably so that the exposed hydrophobic face can bind to the G-protein. Some computational studies of the active state have assumed a rotation of TM6 on activation [54] , but this may be reading unwarranted information into the activation process.
Movies of the essential features of the activation process for the β 2 -adrenergic receptor [49] , extracted from the Molecular Dynamics simulations using essential dynamics [55] , can be found at http://www.biochemsoctrans.org/bst/ 035/bst0350749add.htm.
During a Molecular Dynamics simulation of a GPCR, movement of the helices could conceivably correct some errors in the alignment. However, application of the restraint methodology requires a good alignment at the outset, and so, in the next section, we address the question of the Family A-Family B alignment.
GCR1: a novel tool for improving Family A-Family B alignments
GCR1 is a new plant GPCR [56] that has not yet been assigned to a traditional GPCR family. GCR1 was identified from a database of expressed sequence tags, and was isolated from Arabidopsis thaliana. It is expressed at very low levels in the roots, stems and leaves of Arabidopsis. Antisense experiments have shown that plants have reduced sensitivity to cytokinins, indicating a role in signal transduction, although the ligand is currently unknown. Although its highest similarity is to Dictyostelium cAMP receptors, it shows ∼20% identity with and ∼50% similarity to GPCRs from Family A, Family B and Family E. The alignment between GCR1 and Family A and between GCR1 and Family B, assisted by its alignment with Family E, therefore provides a novel route to determining the Family A-Family B alignment. Selected results from the BLAST search of GCR1 against the GPCRDB (GPCR database; http://www.gpcr.org/7tm/) given in Table 1 confirm the results of Plakidou-Dymock et al. [56] that GCR1 shares some degree of homology with Family A, Family B and Family E GPCRs. Table 1 is entirely consistent with the derivation of the BLOSUM matrices [57] in that the Family A and Family B receptors are identified more strongly using the BLOSUM 45 matrix which is more suited to identifying remote homologues. The ligand for a second plant GPCR, denoted GCR2, has been identified recently [58] , but GCR2 does not appear to be useful in deriving Family A-Family B alignments.
The alignment of TM3, given in Figure 3 (A), is relatively straightforward owing to the conserved cysteine residue present in GCR1 and GPCR Family A, Family B and Family E. This alignment is identical with the one used previously and to that published by Frimurer and Bywater [5] . An analysis of the alignment is given in Figure 3 (B), and this illustrates the benefit of using GCR1 to determine the Family A-Family B alignment. It can be inferred from Figure 3 (B) that there are more identities between Family E and the GCR1 family, here denoted as Family G, than between Family G and any other GPCR family. For this reason, we used Family E to enrich the diversity within the Family G before analysing Family GE (i.e. Family G and Family E)-Family B and Family GEFamily A alignments. Thus there are ten strong and 11 weak identities between Family G and Family E, but only five strong identities and two weak identities between Family A and Family B. There are likewise notable identities between Family GE and Family B (eight strong and four weak) and again between Family GE and Family A (six strong and 11 weak). Some of these weak identities are evident from Figure 3 (A), but some are not because only a limited subset of sequences is shown. When these Family GE-Family B and From a mathematical point of view, a key failing of the cold-spot method is that it uses data only from the most conserved residues and discards data from the least conserved residues. Consequently, we have carried out a linear regression using all the conservation and mean hydrophobicity values, based on [59, 60] , over a window corresponding to the length of a helix (defined by the rhodopsin structure, PDB code 1U19 [4] ). By way of control, we have performed this analysis for TM sequence segments from the serotonin and opsin families and sample hydrophobicity results are given in Figure 4 . Figure 4(A) shows results for TM3, which are typical for TM1-TM6, with the highest peak corresponding to the known alignment. Figure 4(B) shows results for TM7, with the second highest peak corresponding to the known alignment, indicating that the correct alignment should have a reasonable score, but not necessarily the highest score. Figure 4(C) shows that an alternative Family A-Family B TM3 hydrophobicity alignment (+3) has the highest score, but that the preferred alignment, 0, given in Figure 3(A) , has a reasonable score; these scores are possibly lower than in Figures 4(A) and 4(B) because of the lower sequence similarity. The alternative (+3) alignment brings the Family B EGLY (Glu-Glu-Leu-Tyr) sequence into line with the Family A DRY(W) motif. These two alignments (0, +3) would not necessarily be incompatible with each other if a model Family B TM3 were to move slightly intracellularly under Molecular Dynamics simulations since the carboxy groups of the aspartate and the glutamate residues could then potentially occupy similar regions.
The test of whether this approach does indeed prove useful in determining Family A-Family B alignments will be whether it can produce alignments useful for interpreting Family B GPCR function in terms of Family A structure and/or function. Provided that the alignments can be validated in this way, they should then permit the use of restraints in Family B GPCR simulations.
